about
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenAdherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East AfricaCharacteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 preventionResurrecting the triple threat: academic social responsibility in the context of global health researchPattern of neuropsychological performance among HIV positive patients in Uganda.Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in AfricansAcyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.The quinolones and renal infection.Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couplesPre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraceptionImproving facility performance in infectious disease care in Uganda: a mixed design study with pre/post and cluster randomized trial componentsHIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.The etiology of urinary tract infection: traditional and emerging pathogens.The Infectious Diseases Institute at Makerere University, Kampala, Uganda.Urinary tract infections in adults with diabetes.An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in UgandaPreexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionLinkage to HIV care and survival following inpatient HIV counseling and testing.Disease diagnosis in primary care in UgandaEmergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trialFrequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.Standards of therapy for urinary tract infections in adults.Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, UgandaRandomized trial of minocycline in the treatment of HIV-associated cognitive impairment.Excellence in sexually transmitted infection (STI) diagnostics: recognition of past successes and strategies for the future.Rapid tests for sexually transmitted infections (STIs): the way forwardOutcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyBenefits and risks of stavudine therapy for HIV-associated neurologic complications in UgandaEffect of integrated capacity-building interventions on malaria case management by health professionals in Uganda: a mixed design study with pre/post and cluster randomized trial components.Diagnostic challenges of sexually transmitted infections in resource-limited settings.Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans.
P50
Q28270788-A94D487D-A9E3-421F-BB06-680B1CC86A3EQ28533158-27CE960A-5B3E-4023-B30C-50B01EF01D8BQ28744206-C0D442AB-F3C8-4CF6-BCBF-283D085E1919Q30376172-5940D170-B578-49B5-8DCF-E7B0AB6CD1F9Q30445074-8EA68804-1A34-4DBD-A77A-3084517C150FQ30858811-40C08F1E-3495-4174-B9A2-A74185728078Q33394513-A5CAA8A4-4024-4FE2-8F78-24D10EEEA5BAQ33401242-80384BD3-7980-4696-9397-665E18853496Q33436735-F2224E59-C995-408A-989A-EF27D619AB12Q33600252-7C33353F-0512-40C0-9DA5-ADA244395DFBQ33630030-895D1C21-4BD7-4D4C-9E98-656A35C9A84AQ33727305-BF4B0C3F-63B2-468F-A9D8-6116410C647AQ33770153-225E97F7-4E11-4E70-92D8-0160D72413BBQ33881449-73CA03BE-7F33-477A-93CC-AD121B00535EQ34058693-30A56415-7E96-4EBF-A5EE-199790957948Q34060282-72D281F6-89F4-472B-B217-BD5B34002C00Q34061394-1E6D1752-C279-4CD6-B5A0-CC7203FFA0E8Q34135328-33983D8F-E9E4-46DE-8B4D-0799B855EA17Q34179340-184E67D0-69F8-4AD1-8BB0-D524152FD685Q34188547-F310A785-F850-42C2-BD91-D36432B75597Q34214103-6E1298A0-194A-4989-B2BA-88CEA6228D53Q34314648-9D53A122-3E60-4D51-B2BD-68EA1C540EFDQ34700364-73526958-CD49-4BE7-B89B-8F93832576E3Q34860526-2E46C1B7-0596-4066-8BFE-4A22C37C7609Q34887899-F988A440-4D8E-4A9C-A9AC-418E1C86A20BQ35139554-161FF4E3-F7A2-41F6-8374-7B348227162DQ35163040-DD6DAC94-06D6-45AE-B702-B4FDD7B40684Q35464075-9FEDECA9-F4A3-462C-B73F-C2A60E5A4337Q35661895-D5D1AE6A-9E63-4FE3-9750-78E1544B6BB6Q35663363-529A23D7-46BE-4015-9360-D9B123BB350BQ35678689-DDF970BC-8472-4E71-9CE3-62A069D77B0DQ36659385-80F4D4E7-CD04-4BCC-83AB-DDE18BEB26EFQ36668614-5E45B5E2-E340-4548-A26D-93BCBA6F9FABQ36675814-1506D6D5-BA6C-4318-AC62-CB54A7BC8710Q36996124-C227DCDB-9D28-4638-8FF6-D1A511467DDBQ37149013-0F2E4F25-3A10-46B5-AEA6-09D0977B50BCQ37180455-9740533E-4C47-4E85-A7CF-B56E63018EF1Q37453025-1A642796-499E-4208-ACB6-27303DE59144Q37648697-D5292E80-B012-44C5-9D67-5E3C41D02738Q37719760-C9C18539-3659-46C9-8EC5-D2193AA8A5F1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Allan Ronald
@ast
Allan Ronald
@en
Allan Ronald
@es
Allan Ronald
@nl
Allan Ronald
@sl
type
label
Allan Ronald
@ast
Allan Ronald
@en
Allan Ronald
@es
Allan Ronald
@nl
Allan Ronald
@sl
prefLabel
Allan Ronald
@ast
Allan Ronald
@en
Allan Ronald
@es
Allan Ronald
@nl
Allan Ronald
@sl
P106
P1153
7102525911
P21
P31
P496
0000-0002-5746-3490